Login
Coverage Universe
Drugs Covered:
3,034
Drugs Evaluated:
308
Revenue Models:
462
Companies Covered:
781
Companies Evaluated:
33
>>
Advanced Catalyst Search
<<
>>
Advanced Drug Search
<<
>>
Advanced Event Search
<<
Search
Catalysts
Drug Profiles
Impact Events
Company Profiles
Target
Indication
Sample Reports
Special Reports
05/05/08
Bipolar Indication Report
02/01/08
2008 BioMedTracker Outlook
01/08/08
FDA Approval Study
12/18/07
2007 Post-ASH Report
12/12/07
Kuvan PDUFA Sensitivity Analysis
12/07/07
Multiple Sclerosis (MS) Indication Report
12/04/07
2007 Pre-ASH Report
11/09/07
BioMarin (BMRN) Valuation Update
More...
Event Alerts
Date
Lead
Company
Event
Type
Approval
Change
Approval
Likelihood
05/09/08
Novogen (NVGN)
Phenoxodiol for Ovarian Cancer
Subscribers Only
Subscribers Only
Subscribers Only
05/09/08
Takeda (4502.T)
Velcade for Multiple Myeloma (MM)
Subscribers Only
Subscribers Only
Subscribers Only
05/09/08
Adolor (ADLR)
Entereg for Postoperative Ileus
Subscribers Only
Subscribers Only
Subscribers Only
05/09/08
Roche (RHHBY)
Actemra for Rheumatoid Arthritis (RA)
Subscribers Only
Subscribers Only
Subscribers Only
05/09/08
Vanda (VNDA)
Fanapta for Schizophrenia
Subscribers Only
Subscribers Only
Subscribers Only
Expected
Date Range
Lead
Company
Drug
Expected
Catalyst
05/10/08
Subscribers Only
Subscribers Only
Trial Data - Updated Results
05/12/08
Subscribers Only
Subscribers Only
Company - Earnings Announcement
05/12/08
Subscribers Only
Subscribers Only
Company - Earnings Announcement
05/12/08
Subscribers Only
Subscribers Only
Company - Earnings Announcement
05/12/08
Subscribers Only
Subscribers Only
Company - Earnings Announcement
Questions?
Email
Customer Support
Privacy Policy
Important Legal Disclosure
Copyright © 2008 Sagient Research Systems, Inc. All rights reserved.